Discontinue use if NMS occurs or signs & symptoms of tardive dyskinesia appears. CV disease, family history of QT prolongation, cerebrovascular disease or other conditions predisposing to hypotension; history of seizures; extrapyramidal symptoms; hyperglycemia, DM; congenital long QT syndrome, CHF, heart hypertrophy, hypokalaemia, hypomagnesaemia. Patients w/ risk factors for stroke. Avoid abrupt w/drawal. Not to be taken by patients w/ galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Avoid use w/ other neuroleptics. Concomitant use w/ strong hepatic enzyme inducer eg, carbamazepine or phenytoin; medicines increasing QTc interval. May affect ability to drive & use machines. Renal & hepatic impairment. Pregnancy. Avoid use during lactation. Childn & adolescents. Elderly w/ dementia-related psychosis.
Sign Out
